AI assistant
MEDIFAST INC — Director's Dealing 2019
Mar 12, 2019
33899_dirs_2019-03-12_af86b50a-6563-4e27-a36b-67b4d2268bfd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2019-03-08
Reporting Person: SCHLACKMAN SCOTT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-08 | Common Stock | S | 1010 | $130.64 | Disposed | 7045 | Direct |
| 2019-03-08 | Common Stock | S | 990 | $131.21 | Disposed | 6055 | Direct |
Footnotes
F1: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
F2: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.01 to $131.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.